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Background: The need for cost-effective interventions for people suffering from major depressive disorders is
essential. Behavioral activation is an intervention that can largely benefit from the use of new mobile technologies
(for example smartphones). Therefore, developing smartphone-based behavioral activation interventions might be a
way to develop cost-effective treatments for people suffering from major depressive disorders. The aim of this
study will be to test the effects of a smartphone-delivered behavioral activation treatment.
Methods: The study will be a randomized controlled trial with a sample size of 120 participants, with 60 patients in
each group. The treatment group includes an 8-week smartphone-based behavioral activation intervention, with
minimal therapist contact. The smartphone-based intervention consists of a web-based psychoeducation, and a
smartphone application. There is also a back-end system where the therapist can see reports from the patients or
activities being reported. In the attention control group, we will include brief online education and then
recommend use of a smartphone application that is not directly aimed at depression (for example, ‘Effective
meditation’). The duration of the control condition will also be 8 weeks. For ethical reasons we will give the
participants in the control group access to the behavioral activation treatment following the 8-week treatment
period.
Discussions: We believe that this trial has at least three important implications. First, we believe that smartphones
can be integrated even further into society and therefore may serve an important role in health care. Second, while
behavioral activation is a psychological treatment approach for which there is empirical support, the use of a
smartphone application could serve as the therapist’s prolonged arm into the daily life of the patient. Third, as we
have been doing trials on guided Internet treatment for more than 10 years it is now time to move to the next
generation of information technology - smartphones - which are not only relevant for Swedish conditions but also
for developing countries in the world which are increasingly empowered by mobile phones with Internet
connection.
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Major depression is expected to be the disorder with
the highest disease burden in high-income countries by
the year 2030 [1]. Estimated costs of depression are
€177 million and €147 annually per 1 million inhabi-
tants for major and minor depression, respectively [2].
Even if several effective psychological [3] and pharma-
cological treatments [4] are available for the treatment
of depression, it has been shown that current treatment
methods are only capable of reducing the burden of dis-
ease of depressive disorders with about one third [5].
Therefore, there is a need for cost-effective interven-
tions that can be made available to a larger part of the
population suffering from major depressive disorders.
Furthermore, behavioral activation is an intervention
that can largely benefit from the use of new mobile tech-
nologies (for example smartphones). One important feature
of mobile technology is the possibility for the therapist to
reach the patient between sessions and thus create direct
incentives for behavioral activation in everyday life [6].
Therefore, developing smartphone-based behavioral
activation interventions might be a way to develop a
cost-effective treatment for people suffering from major
depressive disorders. Another advantage with behavioral
activation would be that it is more amenable to dissem-
ination, especially via less experienced therapists and/or
self-administration [7].
The efficacy of behavioral activation in the treatment
of major depressive disorders has been established in a
number of studies over the last four decades [8]. Fur-
thermore, a dismantling study showed that behavioral
activation can be as effective as the full cognitive behav-
ioral therapy (CBT) treatment package [9]. In a later
study, behavioral activation was found to be as effective
as antidepressant medication [10], and more effective
than cognitive therapy for more severely depressed
patients. A series of reviews and meta-analyses also show
that behavioral activation is at least as effective as full
CBT packages that include both cognitive and behavioral
components [11]. There are however somewhat different
conceptualizations of behavioral activation, with the
most recent versions covering behavioral avoidance [12].
However, all have activity scheduling as a treatment
component [13]. More recent behavioral activation treat-
ments have incorporated ingredients from Acceptance
and Commitment Therapy (ACT), for example the role
of values when defining treatment goals [14].
Boschen and Casey [6] summarized the advantages of
using mobile phones in CBT, and the same advantages
apply to smartphones: (1) mobile; (2) accepted in society
in general; (3) relatively cheap (this also applies to smart-
phones which on average tend to be less expensive than
computers); (4) they are a device with comparatively low
ongoing maintenance costs; (5) they are a device alreadyowned by a large number of people; (6) they are almost
always on in that they continue to operate; (7) they are
almost always connected; (8) they are programmable,
meaning they are able to run novel applications soft-
ware; (9) they are capable of recording media, including
audio, photographs, and in many cases video, as well as
being able to play or show these media to the user; (10)
they are capable of interacting with the user to allow
input of data using a keypad, keyboard, or touch screen;
and (11) they are generally designed to be easy to use for
most of the population. Moreover, mobile phones can be
integrated into CBT homework, as their use attracts no
attention, allowing users to interact with a handset without
fear of stigma or judgment.
It is now well established that guided self-help treat-
ment can be as effective as face-to-face psychotherapy
for mild to moderate depressive symptoms [15]. Also,
the treatment effects seem to persist during long-term
follow-up [16]. There are, however, to our knowledge no
controlled trial on Internet-delivered pure behavioral
activation and no study using smartphones.
Trial objectives and purpose
The aim of this study will be to test the effects of a
smartphone-delivered behavioral activation treatment.
The study is based on our previous work on guided
Internet-treatment for depression [17], but in this study
the treatment content will be delivered via smartphone,
using a recently developed smartphone application. As
waiting-list control groups are regarded as unsuitable to
test the effects of treatments, we plan to have a non-spe-
cific smartphone application not dealing with depression
or behavioral activation. This will probably be the first
controlled study on smartphone delivered depression
treatment and therefore we will begin by conducting an
efficacy study [18], with participants recruited via mass
media and the Internet. We expect the smartphone
application to be superior to the control condition.
Methods/design
The current study will be a randomized controlled trial
with a sample size of 120 participants. The study proto-
col was approved by the regional Ethics Review Board in
Linköping, Sweden. The protocol was approved by
Ingeborg Moqvist-Lindberg and the reference number is
Dnr: 2011/395-31. Written informed consent was obtained
from all participants after the procedure had been fully
explained.
The intervention
An 8-week smartphone-based behavioral activation
intervention with minimal therapist contact has been
developed by our group. The intervention is based on
our previous experiences with Internet-based depression
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vention consists of a web-based psychoeducation, and a
smartphone application. There is also a back-end system
where the therapist can see reports from the patients or
activities being reported. The concept of the interven-
tion was built with the intention to target some of the
aspects of current Internet-delivered interventions that
could be improved. Although the Internet is effectively
used for distributing psychological treatment programs
to improve mental health [24-26], including treatment of
mild to moderate major depression [27], it has been
argued that Internet-based treatment applications have
limitations [28,29]. One important limitation is the lack
of assimilation into the user’s daily life, which is a crucial
aspect of behavioral activation treatments for depression
[12]. Even if paper versions of text material can be used
and contact with the therapist can be handled via the
Internet, these two options may not be practically feas-
ible. Mobile phones, on the other hand, are often ubiqui-
tous and are hence present when behaviors occur.
Nowadays, access to the Internet can be facilitated by
means of smartphones. Another limitation of Internet-
based treatments for depression, delivered via compu-
ters, is that they tend to be text-based, often reaching
close to 200 pages of reading [20]. Smartphone applica-
tions tend to be more user-friendly and condensed than
regular web pages (for example the difference between a
smartphone application for a newspaper and web pages
for the same newspaper), which could be an attractive
feature for persons with depression who easily feel fati-
gued and need encouragement to work through the pro-
gram [30]. The latter aspect is important, as guidance
appear to be crucial to prevent drop-out from guided
self-help treatments [31], which was recently confirmed
in a meta-analysis [15]. Finally, a challenge for modern
depression treatments is to integrate information tech-
nology in the regular treatment [29]. In other words
face-to-face treatments could benefit from using smart-
phones as an adjunct to the regular sessions, which in
the case of behavioral activation treatments for depres-
sion could facilitate activity scheduling and homework,
which are crucial elements of the treatment. It may also
be possible to reduce the number of sessions.
A prototype of the smartphone application, together with
a psychoeducation, has been tested in a pilot study (Ly KH,
Dahl J, Andersson G: Development and initial evaluation of
a smartphone application based on acceptance and com-
mitment therapy, unpublished). This prototype was how-
ever not directed at depression. The results from the pilot
study gave us useful information and we concluded that the
intervention include some important features that could be
further developed and tested. The results also showed that
the smartphone application was used by some participants
in situations where it was difficult to use a computerconnected to the Internet, for example in the under-
ground train, on the bus and train, and so on. More gener-
ally, this might carry implications that the platform of
mobile phones does not only assimilate an intervention
into a user’s daily life, but also increases the awareness of
the intervention, and thus can increase adherence to the
intervention. In light of these observations we believe it is
feasible to proceed and test if behavioral activation can be
presented in the format of a smartphone application.
Attention control
In the attention control group, we will include brief online
education and then recommend use of a smartphone appli-
cation that is not directly aimed at depression (for example,
‘Effective meditation’). The duration of the control condi-
tion will also be 8 weeks. For ethical reasons we will give
the participants in the control group access to the behav-
ioral activation treatment following the 8 week treatment
period.
Sample size
We will include a total of 120 individuals. With 60
patients in each group, an effect size of Cohen’s d=0.60
will be statistically significant (80% power, 5% level), which
we will view as a clinically relevant difference between the
two conditions.
Referral and recruitment
Patients will be recruited via advertisement in newspapers,
other media, and the Internet. Only persons who already
use smartphones will be invited to participate.
Inclusion criteria
We will include participants with an ongoing primary
diagnosis of major depression of mild to moderate charac-
ter. Diagnoses will be made over the telephone using the
Mini-International Neuropsychiatric Interview (MINI)
[32]. To administer clinical interviews via telephone has
shown to give the same result as doing it face-to-face
[33,34]. Medication will be allowed with the requirement
that the dose is stable. Consenting participants need to be
fluent in Swedish and have access to the Internet as well
as a smartphone.
Exclusion criteria
Persons with suicidal intent and patients for whom the
depression is directly linked to another major primary
psychiatric disorder (for example, psychosis or bipolar
disorder) will be excluded and referred to other treat-
ment resources. In addition, people with a history of
misuse of alcohol or drugs will be excluded.
Informed consent
Participation will require a written informed consent.
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Participants can at any time withdraw from the treatment
or the study without specifying the reason.
Safety monitoring and reporting
We will adhere to the Swedish Personal Data Act. No sen-
sitive data will be saved on a computer in which the person
providing data can be identified. All Internet and smart-
phone activities will be highly secure, with encrypted infor-
mation as well as no contact outside of a closed contact
system. If participants decline further participation, the
data will be removed.
Outcome measures
The primary outcome measures will be self-assessed de-
pression using the Beck Depression Inventory (BDI-II)
[35] and the Patient Health Questionnaire-9 (PHQ-9)
[36]. PHQ-9 consists of nine items, each scored 0–3 and
with a total score range from 0 to 27. PHQ-9 shows a
sensitivity of 0.77 (0.71–0.84) and a specificity of 0.94
(0.90–0.97) [37]. BDI was constructed to assess the
degree of depression in adolescents and adults, and con-
sists of 21 questions [38]. The BDI has been extensively
validated in various studies. A review of the BDI’s in-
ternal consistency estimates yielded a mean coefficient
alpha of 0.86 for psychiatric patients and 0.81 for non-
psychiatric subjects [39]. For psychiatric patients the
test-retest reliability has been reported to range from
0.48 to 0.86, whereas the coefficients for non-psychiatric
subjects ranged from 0.60 to 0.83 [39]. We will also ad-
minister the MINI [32]. This will be done via telephone
to make participation possible for persons who live in all
regions of Sweden. Moreover, an independent (blind)
rating of clinical global impression-improvement scale
(CGI) [40] will be performed. Hence, all patients will be
interviewed again after the treatment period. All self-re-
port measures will be administered via the Internet,
which will facilitate 1-year and 2-year follow-ups.
According to Thorndike et al. [41], self-report measures
administrated via the Internet show good validity. We
estimate a drop-out from completing the post-treatment
measures of approximately 30%. This would lead to a
reduced sample size of 84, which will maintain the esti-
mated power. While the cross-over design will prohibit
conclusions regarding specific long-term effects, the
long-term effect of the new treatment format (that is
smartphones) is not yet investigated, making the follow-
up informative in the case both treatments are ineffect-
ive. Moreover, switching treatment will be optional and
we will be able to investigate subgroups that only
complete one of the treatments. The main outcome of
interest in the study is if smartphone-enabled behavioral
activation is superior to attention control (use of smart-
phone with no reference to depression or behavioralactivation). We expect a moderate difference on the
main outcome measures of depression. We also expect
the number of responders (defined as a decrease accord-
ing to Jacobson on the BDI-II [35] and PHQ-9 [36] and
remission to lower levels of symptoms on the MINI-
mood disorders section [32]) to be larger in the behav-
ioral activation arm.Moderators and mediators
As secondary outcome we will include the Beck Anxiety
Inventory (BAI) [42], the Quality of Life Inventory
(QOLI) [43] and Acceptance and Action Questionnaire
(AAQ-II) [44]. The BAI is a 21-item self-report inven-
tory for measuring the severity of anxiety in psychiatric
populations [42]. De Beurs et al. [45] showed that the
BAI has high internal consistency in panic patients
(Cronbach’s a = 0.92) and good test-retest reliability
(0.83). The QOLI consists of 16 areas rated by the sub-
ject concerning importance and satisfaction. The instru-
ment’s internal consistency is high, between a = 0.77 and
0.89, and the 1 month test-retest reliability lies between
r = 0.80 and 0.91 [43]. The AAQ-II is a 10-item, 7-point
Likert scale that assesses psychological flexibility - a
term for the ability to accept unwanted internal experi-
ences and engage in valued actions. The AAQ II has
shown good reliability (test-retest reliability = 0.81–0.87)
and validity [44].
Other measures will be included as potential predic-
tors of outcome such as education, number of previous
episodes, and so on. Finally, we will include the Trimbos
and Institute of Medical Technology Assessment Cost
Questionnaire for Psychiatry (TIC-P [46]), which is a
questionnaire designed to measure health related costs.
Cost-effectiveness studies also often involved a measure
called the EQ-5D [47]. The study will follow the guide-
lines given in the CONSORT statement [48,49], with the
exception of double-blinding, which is not possible in
psychotherapy studies. Other features such as intention-
to-treat (mixed models approach [50]) and statistical
power calculations will be adhered to. The theoretical
rationale for smartphone supported behavioral activation
is the observation that activity is related to depressive
symptoms [8] and that behavioral change may be facili-
tated by the increased adherence provided by the
smartphone.Statistical analysis
An intention-to-treat design will be used when analyzing
post-treatment data and data collected at 1-year follow-up.
Between-group changes at post-treatment and at 1-year
follow-up will be calculated using analyses of covariance
(ANCOVAs), with pre-treatment scores as the covariate.
Effect sizes between and within the two groups will be
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standard deviation.Discussion
We believe that this trial has at least three important
implications. First, we believe that smartphones can be
integrated even further into society and therefore may
serve an important role in healthcare. It has been sug-
gested that mobile phones have become an important
part of our everyday lives, and that they already are pro-
viding us with several services, for example phone calls,
text and multimedia messages, cameras, music, calendar
and the Internet. Therefore, adding applications to facili-
tate health into the platform may be perceived by the
user to be a natural step, and thus can be reached out to
more people. In fact, there are already several smart-
phone applications aimed at mental health, but unfortu-
nately a vast majority have not been tested in research
and may be limited in terms of content. Should we be
able to show that mild to moderate depression can be
treated effectively by means of a supported smartphone
application, it is highly possible that this will be followed
by applications for other health problems.
Second, while behavioral activation is a psychological
treatment approach for which there is empirical support,
the use of a smartphone application could serve as the
therapist’s prolonged arm into the daily life of the patient.
Since the theoretical understanding of the mechanisms be-
hind behavioral activation suggests that behaviors should
be immediately reinforced when they occur, our smart-
phone application may lead to improved compliance com-
pared to our earlier Internet treatments.
Finally, from a psychiatric research point of view our
group is probably among the most active research groups
in Sweden when it comes to conducting randomized con-
trolled trials on psychiatric conditions. As we have been
doing trials on guided Internet treatment for more than
10 years it is now time to move to the next generation of
information technology - smartphones - which are not only
relevant for Swedish conditions but also for developing
countries in the world which are increasingly empowered
by mobile phones with Internet connection.Trial status
Active, not recruiting. However, when the manuscript was
submitted to the journal the study was in recruitment.Competing interests
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